Spiroxasone (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name) is a synthetic, steroidal antimineralocorticoid of the spirolactone group which was developed as a diuretic and antihypertensive agent but was never marketed.[1][2] It was synthesized and assayed in 1963.[1] The drug is 7α-acetylthiospirolactone with the ketone group removed from the C17α spirolactone ring.[1] Similarly to other spirolactones like spironolactone, spiroxasone also possesses antiandrogen activity.[3][4]
Spiroxasone [...] is also an anti-androgen [379].
This article about a steroid is a stub. You can help Wikipedia by expanding it.
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.